First Person Receives Experimental Ebola Vaccine in Global Trial

The first human recipient of a new experimental Ebola vaccine has been administered the treatment in an early-stage clinical trial. The development is a global health milestone with relevance to African epidemic preparedness given the continent's ongoing Ebola exposure.